Clinical analysis of osteonecrosis of the jaw in patients with rheumatoid arthritis: risk factors and oral health implications
摘要
Osteonecrosis of the jaw (ONJ) is a rare but serious complication in patients with rheumatoid arthritis (RA), and its risk factors remain unclear. This study aimed to clarify the clinical characteristics and risk factors for ONJ in patients with RA.
MethodsWe retrospectively analyzed 35 patients with RA who developed ONJ against 276 control patients with RA who received collaborative medical-dental care but did not develop ONJ. Group comparisons were performed using Mann–Whitney U and Fisher’s exact tests; logistic regression was performed to determine the risk factors (significance set at p < 0.05).
ResultsUnivariate analysis revealed that the ONJ group exhibited a higher prevalence of rheumatoid factor positivity (p = 0.021), advanced RA (Steinbrocker stage III–IV; p < 0.0001), osteoporosis (p < 0.0001), low body mass index (< 18.5; p = 0.041), dental infections (p = 0.011), and regular use of nonsteroidal anti-inflammatory drugs (p = 0.004). The use of bone resorption inhibitors was also higher in the ONJ group (p < 0.0001), particularly for treatment rather than prevention (p = 0.020). Multivariate analysis identified osteoporosis (OR 7.82, 95% CI 7.21–8.48, p < 0.001), dental infection (OR 2.25, 95% CI 2.07–2.45, p < 0.001), and advanced stage of RA (OR 4.10, 95% CI 3.68–4.56, p < 0.001) as independent risk factors for ONJ.
ConclusionsONJ in patients with RA arises from synergistic effects of osteoporosis, advanced joint destruction, and dental infection. Clinicians should focus on identifying high-risk patients based on RA severity (Steinbrocker stage III–IV) and managing modifiable factors through close medical-dental collaboration to prevent ONJ.